glp-1 fitness exercise news ISSA Launches Support Course for Trainers The GLP-1 Revolution: Why Health

For individuals managing weight or metabolic health while breastfeeding, this decision requires balancing treatment goals with infant safety

Patients and Interventions/Exposure : New users of semaglutide (n= 613) and liraglutide (n=4,144), which are GLP-1 receptor agonists approved for diabetes, and users of buproprion-naltrexone (n= 654), an Federal Drug Administration (FDA)-approved weight loss agent, which served as active comparator

Use of the injections started increasing in 2022, followed by "a sharp increase" in 2024

Glucose-dependent Insulinotropic polypeptide activates the Raf-Mek1/2-ERK1/2 Module via a Cyclic AMP/cAMP-dependent Protein Kinase/Rap1-mediated Pathway